YURiA-PHARM Among the Largest Private Wartime Investors
According to NV magazine, the YURiA-PHARM group is in the list of the largest private investors in Ukraine during the full-scale war.
Between February 2022 and February 2026, the company’s investment volume exceeded 2.8 billion UAH.
In total, the 45 leading companies in the ranking invested over 400 billion UAH into the Ukrainian economy over these four years. For YURiA-PHARM, this recognition confirms its consistent commitment to long-term development and modernization, even under wartime conditions.
Key Areas of YURiA-PHARM Investment
The company invests in areas that define its long-term resilience and competitiveness:
- R&D development and the creation of infrastructure for new product development;
- Construction and modernization of production facilities and warehouse infrastructure;
- Technological equipment for production, warehousing, and office sites;
- Expansion of production capabilities in the company’s priority sectors;
- IT infrastructure and digital solutions necessary for increasing operational efficiency and ensuring regulatory compliance in international markets;
- Energy independence, which is a critical condition for operational continuity;
- Strategic assets and new infrastructure opportunities for the development of subsequent business stages.
Overall, YURiA-PHARM reinvests over 80% of its profit, consistently allocating resources to the development of technology, innovation, and the company’s international capabilities.
